# Commission Implementing Regulation (EU) 2017/1276 of 14 July 2017 approving peracetic acid generated from tetraacetylethylenediamine and sodium percarbonate as an existing active substance for use in biocidal products of product-types 2, 3 and 4 (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

The purity indicated in this column was the minimum degree of purity of the active substance evaluated. The active substance in the product placed on the market can be of equal or different purity if it has been proven to be technically equivalent to the evaluated active substance.
Common Name
IUPAC NameIdentification Numbers
Minimum degree of purity of the active substance
Date of approval
Expiry date of approval
Product type
Specific conditions
Peracetic acid generated from tetraacetylethylenediamine and sodium percarbonate
IUPAC Name:
Peroxyethanoic acid
EC No: 201-186-8
CAS No: 79-21-0
Precursors:
IUPAC Name: N,N′-ethane-1,2-diylbis(N-acetylacetamide)
EC No: 234-123-8
CAS No: 10543-57-4
IUPAC Name: Sodium percarbonate
EC No: 239-707-6
CAS No: 15630-89-4
The specification for peracetic acid generated in situ is based on the precursors tetraacetylethylenediamine and sodium percarbonate.
The minimum degree of purity of tetraacetylethylenediamine is 99,0 % and the minimum degree of purity of the sodium percarbonate is 85,1 %
1 January 2019
31 December 2028
2
The authorisations of biocidal products are subject to the following conditions:
(1) The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any use covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance.
(2) In view of the risks identified for the uses assessed, the product assessment shall pay particular attention to:
(a) industrial and professional users;
(b) surface water for products used in laundry disinfection in closed washing machines in households.
3
The authorisations of biocidal products are subject to the following conditions:
(1) The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any use covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance.
(2) In view of the risks identified for the uses assessed, the product assessment shall pay particular attention to industrial and professional users.
4
The authorisations of biocidal products are subject to the following conditions:
(1) The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any use covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance.
(2) In view of the risks identified for the uses assessed, the product assessment shall pay particular attention to industrial and professional users.

---
Source: https://www.legislation.gov.uk/eur/2017/1276/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2017-1276/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.